switching between glp-1 agonists Frontiers Switching from tirzepatide to retatrutide:

GLP-1 inhibits adenosine triphosphate (ATP)-regulated potassium (K + )channels, increases activity of L-type voltage gated calcium channels, and triggers opening of non-specific cation channels through PKA and exchange protein directly activated by cAMP (EPAC), two cAMP-dependent processes [48], [49]

The Reflexive Nature of a Successful Weight Loss Drug The exponential rise in search trends for terms related to these drugs (GLP-1, Wegovy, Mounjaro, Ozempic) speaks to a reflexive relationship that is catalyzed by the nature of social media

To examine any litigation that resulted from paragraph IV challenges, we used the LexisNexis LexMachina database, which gives information on patent lawsuits found in the Public Access to Court Electronic Records database filed since January 1, 2000

January 2025: The defendants in the MDL have filed a new motion to dismiss many of the claims made in the plaintiffs master complaint

Most notable is a study of cardiovascular outcomes among 2,287 patients with type 2 diabetes and obesity who underwent bariatric surgery at Cleveland Clinic and 11,435 matched controls ( JAMA

Among American adults who have taken these medications, 62% said they used them both to treat a chronic condition such as diabetes or heart disease and to lose weight, including 39% who said they used the medications only to treat a chronic condition